News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Deals
Sanofi-Aventis (France) Extends Genzyme Corporation Bid To February 15
January 24, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bloomberg -- Sanofi-Aventis SA extended its $18.5 billion takeover offer for Genzyme Corp. again, giving France’s biggest drugmaker more time to reach an agreement with the U.S. biotechnology company.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Sanofi
MORE ON THIS TOPIC
Deals
Biotech is back, with H1 progress smoothing glide path through end of year: Truist
September 4, 2026
·
3 min read
·
Annalee Armstrong
Antibody-drug conjugate (ADC)
Pfizer punts Seagen ADC, further muddying value of the $43B buyout
September 4, 2026
·
2 min read
·
Tristan Manalac
Deals
GSK inks another Asia alliance, betting up to $1.3B for HUTCHMED’s cancer therapy
September 3, 2026
·
1 min read
·
Tristan Manalac
Mergers & acquisitions
Biopharma reverse mergers rise 1,600% in Q3 to rival IPOs
September 2, 2026
·
3 min read
·
Gabrielle Masson
